Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunological Characteristics of Patients Receiving Ultra-Short Treatment for Chronic Hepatitis C.

Frontiers in cellular and infection microbiology - 1 Jan 2022

Madsen Lone Wulff, Christensen Peer Brehm, Øvrehus Anne, Bryde Dorthe Marie Sjødahl, Holm Dorte Kinggaard, Lillevang Søren Thue, Nielsen Christian

Abstract excerpt

Reducing the treatment duration for chronic hepatitis C could be an important tool in the effort to reach the elimination goals set by the World Health Organization. The current challenge is to predict the target group who will achieve sustained virological response at week 12 (SVR12) with shorter treatment duration. The aim of this exploratory study was to characterize immune subsets with focus on inhibitory...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to CD8-Positive T-Lymphocytes

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genotype

Share to Hepacivirus

Share to Hepatitis C, Chronic

Share to Programmed Cell Death 1 Receptor

Share to Recurrence

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 35832377
DOI: 10.3389/fcimb.2022.885824
PMCID: PMC9271618

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunological Characteristics of Patients Receiving Ultra-Short Treatment for Chronic Hepatitis C.PMID 35832377Read ↗

Liver environment and HCV replication affect human T-cell phenotype and expression of inhibitory receptors.Semantic proximity Read ↗

T cell subsets in chronic hepatitis C patients genotype 4 who achieved SVR following DAAs TherapySemantic proximity Read ↗

Double Positive CD4+CD8+ (DP) T-Cells Display Distinct Exhaustion Phenotype in Chronic Hepatitis C.Semantic proximity Read ↗

Dynamic changes of T cell receptor repertoires in patients with hepatitis B virus-related acute-on-chronic liver failureSemantic proximity Read ↗

The role of CCR5/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection.Semantic proximity Read ↗

Short-term therapy for patients with hepatitis C virus genotype 2 or 3 infection.Semantic proximity Read ↗

Exhausted phenotype of circulating CD8+ T cell subsets in hepatitis B virus carriers.Semantic proximity Read ↗

Optimal treatment duration for patients with HCV genotype 1 infection.Semantic proximity Read ↗

Peripheral blood correlates of virologic relapse after Sofosbuvir and Ribavirin treatment of Genotype-1 HCV infection.Semantic proximity Read ↗

Longitudinal characterization of phenotypic profile of T cells in chronic hepatitis B identifies immune markers predicting HBsAg lossSemantic proximity Read ↗

Coexpression of PD-1, 2B4, CD160 and KLRG1 on Exhausted HCV-Specific CD8+ T Cells Is Linked to Antigen Recognition and T Cell DifferentiationSemantic proximity Read ↗

According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1low HCV-Specific CD8+ Cell Reactivity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.